Evidence map›Paper›PMID 36593996›Full record

ArticleSchizophrenia research. Cognition2023

Evaluating construct and criterion validity of NeuroScreen in assessing neurocognition among hospitalized Ugandan first-episode psychosis patients.

Nana Asiedu, Emmanuel Kiiza Mwesiga, Dickens Akena, Corey Morrison, Joy Louise Gumikiriza-Onoria, Angel Nanteza, Juliet Nakku, Nastassja Koen, Noeline Nakasujja, Wilber Ssembajjwe and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Schizophrenia research. Cognition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Vascular and inflammatory biomarkers linked to neurocognition in Ugandan youth with perinatal HIV on dolutegravir.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Nana AsieduHIV Center for Behavioral Studies, New York State Psychiatric Institute and Columbia University, 1051 Riverside Drive, New York, NY 10032, United States of America.
Emmanuel Kiiza MwesigaMakerere University College of Health Sciences, School of Medicine, Department of Psychiatry, 7072 Upper Mulago Hill, Mulago Hospital Complex, Uganda.
Dickens AkenaMakerere University College of Health Sciences, School of Medicine, Department of Psychiatry, 7072 Upper Mulago Hill, Mulago Hospital Complex, Uganda.
Corey MorrisonHIV Center for Behavioral Studies, New York State Psychiatric Institute and Columbia University, 1051 Riverside Drive, New York, NY 10032, United States of America.
Joy Louise Gumikiriza-OnoriaMakerere University College of Health Sciences, School of Medicine, Department of Psychiatry, 7072 Upper Mulago Hill, Mulago Hospital Complex, Uganda.
Angel NantezaButabika National Referral Mental Hospital, Plot 2 Kirombe-Butabika Road, Kampala, Uganda.
Juliet NakkuButabika National Referral Mental Hospital, Plot 2 Kirombe-Butabika Road, Kampala, Uganda.
Nastassja KoenDepartment of Psychiatry and Mental Health, University of Cape Town, Rondebosch, Cape Town, South Africa.
Noeline NakasujjaMakerere University College of Health Sciences, School of Medicine, Department of Psychiatry, 7072 Upper Mulago Hill, Mulago Hospital Complex, Uganda.
Wilber SsembajjweMedical Research Council, Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine, PO Box 49, Entebbe Plot 51-59 Nakiwogo Road, Uganda.
Christopher M FerrarisHIV Center for Behavioral Studies, New York State Psychiatric Institute and Columbia University, 1051 Riverside Drive, New York, NY 10032, United States of America.
Anthony F SantoroHIV Center for Behavioral Studies, New York State Psychiatric Institute and Columbia University, 1051 Riverside Drive, New York, NY 10032, United States of America.
Dan J SteinDepartment of Psychiatry and Mental Health, University of Cape Town, Rondebosch, Cape Town, South Africa.
Reuben N RobbinsHIV Center for Behavioral Studies, New York State Psychiatric Institute and Columbia University, 1051 Riverside Drive, New York, NY 10032, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Neurocognitive impairment (NCI) is commonly exhibited among patients experiencing their first episode of psychosis. However, there are few resources in many low-income countries, such as Uganda, that allow for the administration of extensive neurocognitive test batteries for the detection of NCI. Methods: We enrolled 112 participants FEP patients and matched controls at Butabika Mental Referral Hospital. Each participant completed Results: There was a large, statistically significant correlation between overall performance on Conclusion: There was a moderate positive correlation between overall performance on both batteries.

Indexed as

First episode psychosisLow-income countryMATRIC consensus cognitive batteryNeurocognitive impairmentNeuropsychological assessmentNeuroScreenUganda

Identifiers

PMID36593996
PMCPMC9803945

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.